ONCR || News

CheckMate 067 ends ipilimumab’s reign in first-line metastatic melanoma

Posted on: 01/06/2015 - 18:29

CHICAGO – Nivolumab and nivolumab plus ipilimumab are superior to ipilimumab alone in first-line metastatic melanoma, results from the phase III CheckMate 067 study suggest. After a minimum of 9...

Field of Interest: Oncology

Type: News Item

VIDEO: Dual immunotherapy more powerful in melanoma, but where do we go from here?

Posted on: 01/06/2015 - 17:30

CHICAGO – Combining the immunotherapy antibodies nivolumab and ipilimumab induced more robust responses in untreated advanced melanoma when used together than as single agents, according to phase III...

Field of Interest: Oncology

Type: News Item

Adding enhanced MR to CT might improve diagnosis, outcomes in hepatocellular carcinoma

Posted on: 01/06/2015 - 07:01

Among patients with single-nodule hepatocellular carcinomas diagnosed by computed tomography, further imaging with gadoxetic acid–enhanced magnetic resonance (MR) revealed more tumors and was tied to...

Field of Interest: Oncology

Type: News Item

Adding enhanced MR to CT might improve diagnosis, outcomes in hepatocellular carcinoma

Posted on: 01/06/2015 - 07:01

Field of Interest: Gastroentero...

Type: News Item

ASCO: Eribulin results ‘a giant step for sarcoma’

Posted on: 31/05/2015 - 15:18

CHICAGO – For the first time ever, a new drug has shown a survival advantage – albeit a small one – in metastatic soft tissue sarcomas, diseases that are almost without exception unresponsive to...

Field of Interest: Oncology

Type: News Item

VIDEO: Lymphadenectomies don’t boost survival in melanoma with SLN micrometastases

Posted on: 30/05/2015 - 21:30

CHICAGO – Complete lymph node dissection did not improve survival in a prospective, randomized trial of 483 patients with stage III melanoma and micrometastases in their sentinel lymph node...

Field of Interest: Oncology

Type: News Item

GADOLIN: Combination improves PFS in rituximab-refractory indolent NHL

Posted on: 30/05/2015 - 20:35

CHICAGO – Progression-free survival for patients with rituximab-refractory indolent non-Hodgkin’s lymphoma was effectively doubled with a combination of obinutuzumab and bendamustine, compared with...

Field of Interest: Oncology

Type: News Item

VIDEO: Nivolumab puts brakes on advanced liver cancer

Posted on: 30/05/2015 - 15:44

CHICAGO – Immune checkpoint inhibition with nivolumab every 2 weeks provides a better response than does standard treatment for advanced liver cancer, phase I/II results suggest. The overall...

Field of Interest: Oncology

Type: News Item

DDW: Aspirin cuts incidence of noncardiac gastric adenocarcinomas

Posted on: 28/05/2015 - 20:02

WASHINGTON – Even wonder drugs have their limits: Aspirin use was associated with a significant reduction in the incidence of noncardiac gastric adenocarcinoma, but it had no effect on the incidence...

Field of Interest: Gastroentero...

Type: News Item

DDW: Aspirin cuts incidence of noncardiac gastric adenocarcinomas

Posted on: 28/05/2015 - 20:02

Field of Interest: Oncology

Type: News Item

« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters